Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 317

1.

Volume-of-interest-based supervised cluster analysis for pseudo-reference region selection in [18F]DPA-714 PET imaging of the rat brain.

Vieira IF, Ory D, Casteels C, Lima FRA, Van Laere K, Bormans G, Koole M.

EJNMMI Res. 2018 Dec 27;8(1):112. doi: 10.1186/s13550-018-0467-4.

2.

Glucose metabolic brain patterns to discriminate amyotrophic lateral sclerosis from Parkinson plus syndromes.

Devrome M, Van Weehaeghe D, De Vocht J, Van Damme P, Van Laere K, Koole M.

EJNMMI Res. 2018 Dec 13;8(1):110. doi: 10.1186/s13550-018-0458-5.

3.

18F-JNJ-64413739, a novel PET ligand for the P2X7 ion channel: radiation dosimetry, kinetic modeling, test-retest variability and occupancy of the P2X7 antagonist JNJ-54175446.

Koole M, Schmidt M, Hijzen A, Ravenstijn P, Vandermeulen C, Van Weehaeghe D, Serdons K, Celen S, Bormans G, Ceusters M, Zhang W, Van Nueten L, Kolb H, de Hoon J, Van Laere K.

J Nucl Med. 2018 Sep 27. pii: jnumed.118.216747. doi: 10.2967/jnumed.118.216747. [Epub ahead of print]

PMID:
30262518
4.

Quantifying SV2A density and drug occupancy in the human brain using [11C]UCB-J PET imaging and subcortical white matter as reference tissue.

Koole M, van Aalst J, Devrome M, Mertens N, Serdons K, Lacroix B, Mercier J, Sciberras D, Maguire P, Van Laere K.

Eur J Nucl Med Mol Imaging. 2019 Feb;46(2):396-406. doi: 10.1007/s00259-018-4119-8. Epub 2018 Aug 18.

PMID:
30121895
5.

Single-word comprehension deficits in the nonfluent variant of primary progressive aphasia.

Schaeverbeke J, Gabel S, Meersmans K, Bruffaerts R, Liuzzi AG, Evenepoel C, Dries E, Van Bouwel K, Sieben A, Pijnenburg Y, Peeters R, Bormans G, Van Laere K, Koole M, Dupont P, Vandenberghe R.

Alzheimers Res Ther. 2018 Jul 18;10(1):68. doi: 10.1186/s13195-018-0393-8.

6.

Distinct [18F]THK5351 binding patterns in primary progressive aphasia variants.

Schaeverbeke J, Evenepoel C, Declercq L, Gabel S, Meersmans K, Bruffaerts R, Adamczuk K, Dries E, Van Bouwel K, Sieben A, Pijnenburg Y, Peeters R, Bormans G, Van Laere K, Koole M, Dupont P, Vandenberghe R.

Eur J Nucl Med Mol Imaging. 2018 Dec;45(13):2342-2357. doi: 10.1007/s00259-018-4075-3. Epub 2018 Jun 26.

7.

Behavioral Symptoms in Premanifest Huntington Disease Correlate with Reduced Frontal CB1R Levels.

Ceccarini J, Ahmad R, Van de Vliet L, Casteels C, Vandenbulcke M, Vandenberghe W, Van Laere K.

J Nucl Med. 2019 Jan;60(1):115-121. doi: 10.2967/jnumed.118.210393. Epub 2018 Jun 22.

PMID:
29934407
8.

A high-quality genome sequence of Rosa chinensis to elucidate ornamental traits.

Hibrand Saint-Oyant L, Ruttink T, Hamama L, Kirov I, Lakhwani D, Zhou NN, Bourke PM, Daccord N, Leus L, Schulz D, Van de Geest H, Hesselink T, Van Laere K, Debray K, Balzergue S, Thouroude T, Chastellier A, Jeauffre J, Voisine L, Gaillard S, Borm TJA, Arens P, Voorrips RE, Maliepaard C, Neu E, Linde M, Le Paslier MC, Bérard A, Bounon R, Clotault J, Choisne N, Quesneville H, Kawamura K, Aubourg S, Sakr S, Smulders MJM, Schijlen E, Bucher E, Debener T, De Riek J, Foucher F.

Nat Plants. 2018 Jul;4(7):473-484. doi: 10.1038/s41477-018-0166-1. Epub 2018 Jun 11.

PMID:
29892093
9.

Brain Imaging of Alzheimer Dementia Patients and Elderly Controls with 18F-MK-6240, a PET Tracer Targeting Neurofibrillary Tangles.

Lohith TG, Bennacef I, Vandenberghe R, Vandenbulcke M, Salinas CA, Declercq R, Reynders T, Telan-Choing NF, Riffel K, Celen S, Serdons K, Bormans G, Tsai K, Walji A, Hostetler ED, Evelhoch JL, Van Laere K, Forman M, Stoch A, Sur C, Struyk A.

J Nucl Med. 2019 Jan;60(1):107-114. doi: 10.2967/jnumed.118.208215. Epub 2018 Jun 7.

PMID:
29880509
10.

Multicenter validation of [18F]-FDG PET and support-vector machine discriminant analysis in automatically classifying patients with amyotrophic lateral sclerosis versus controls.

D'hulst L, Van Weehaeghe D, Chiò A, Calvo A, Moglia C, Canosa A, Cistaro A, Willekens SM, De Vocht J, Van Damme P, Pagani M, Van Laere K.

Amyotroph Lateral Scler Frontotemporal Degener. 2018 Jun 4:1-8. doi: 10.1080/21678421.2018.1476548. [Epub ahead of print]

PMID:
29862846
11.

Effects of alcohol exposure on the glutamatergic system: a combined longitudinal 18 F-FPEB and 1 H-MRS study in rats.

de Laat B, Weerasekera A, Leurquin-Sterk G, Gsell W, Bormans G, Himmelreich U, Casteels C, Van Laere K.

Addict Biol. 2018 May 23. doi: 10.1111/adb.12635. [Epub ahead of print]

PMID:
29790622
12.

Automated assessment of FDG-PET for differential diagnosis in patients with neurodegenerative disorders.

Nobili F, Festari C, Altomare D, Agosta F, Orini S, Van Laere K, Arbizu J, Bouwman F, Drzezga A, Nestor P, Walker Z, Boccardi M; EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders.

Eur J Nucl Med Mol Imaging. 2018 Jul;45(9):1557-1566. doi: 10.1007/s00259-018-4030-3. Epub 2018 May 2. Review.

PMID:
29721650
13.

On the optimal z-score threshold for SISCOM analysis to localize the ictal onset zone.

De Coster L, Van Laere K, Cleeren E, Baete K, Dupont P, Van Paesschen W, Goffin KE.

EJNMMI Res. 2018 Apr 17;8(1):34. doi: 10.1186/s13550-018-0381-9.

14.

Positron emission tomography imaging of cerebral glucose metabolism and type 1 cannabinoid receptor availability during temporal lobe epileptogenesis in the amygdala kindling model in rhesus monkeys.

Cleeren E, Casteels C, Goffin K, Koole M, Van Laere K, Janssen P, Van Paesschen W.

Epilepsia. 2018 May;59(5):959-970. doi: 10.1111/epi.14059. Epub 2018 Apr 17.

PMID:
29663353
15.

The Variable Effect of Polyploidization on the Phenotype in Escallonia.

Denaeghel HER, Van Laere K, Leus L, Lootens P, Van Huylenbroeck J, Van Labeke MC.

Front Plant Sci. 2018 Mar 20;9:354. doi: 10.3389/fpls.2018.00354. eCollection 2018.

16.

Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease.

Mattsson N, Groot C, Jansen WJ, Landau SM, Villemagne VL, Engelborghs S, Mintun MM, Lleo A, Molinuevo JL, Jagust WJ, Frisoni GB, Ivanoiu A, Chételat G, Resende de Oliveira C, Rodrigue KM, Kornhuber J, Wallin A, Klimkowicz-Mrowiec A, Kandimalla R, Popp J, Aalten PP, Aarsland D, Alcolea D, Almdahl IS, Baldeiras I, van Buchem MA, Cavedo E, Chen K, Cohen AD, Förster S, Fortea J, Frederiksen KS, Freund-Levi Y, Gill KD, Gkatzima O, Grimmer T, Hampel H, Herukka SK, Johannsen P, van Laere K, de Leon MJ, Maier W, Marcusson J, Meulenbroek O, Møllergård HM, Morris JC, Mroczko B, Nordlund A, Prabhakar S, Peters O, Rami L, Rodríguez-Rodríguez E, Roe CM, Rüther E, Santana I, Schröder J, Seo SW, Soininen H, Spiru L, Stomrud E, Struyfs H, Teunissen CE, Verhey FRJ, Vos SJB, van Waalwijk van Doorn LJC, Waldemar G, Wallin ÅK, Wiltfang J, Vandenberghe R, Brooks DJ, Fladby T, Rowe CC, Drzezga A, Verbeek MM, Sarazin M, Wolk DA, Fleisher AS, Klunk WE, Na DL, Sánchez-Juan P, Lee DY, Nordberg A, Tsolaki M, Camus V, Rinne JO, Fagan AM, Zetterberg H, Blennow K, Rabinovici GD, Hansson O, van Berckel BNM, van der Flier WM, Scheltens P, Visser PJ, Ossenkoppele R.

Alzheimers Dement. 2018 Jul;14(7):913-924. doi: 10.1016/j.jalz.2018.02.009. Epub 2018 Mar 28.

PMID:
29601787
17.

Fatty Acid Amide Hydrolase Inhibition by JNJ-42165279: A Multiple-Ascending Dose and a Positron Emission Tomography Study in Healthy Volunteers.

Postnov A, Schmidt ME, Pemberton DJ, de Hoon J, van Hecken A, van den Boer M, Zannikos P, van der Ark P, Palmer JA, Rassnick S, Celen S, Bormans G, van Laere K.

Clin Transl Sci. 2018 Jul;11(4):397-404. doi: 10.1111/cts.12548. Epub 2018 Mar 25.

18.

Mixed response on regorafenib treatment for GIST (gastro-intestinal stromal tumor) according to 18F-FDG-PET/CT.

Van Weehaeghe D, Gheysens O, Vandecaveye V, Schöffski P, Van Laere K, Deroose CM.

BMC Cancer. 2018 Mar 5;18(1):253. doi: 10.1186/s12885-018-4154-7.

19.

Glutamatergic Biomarkers for Cocaine Addiction: A Longitudinal Study Using MR Spectroscopy and mGluR5 PET in Self-Administering Rats.

de Laat B, Weerasekera A, Leurquin-Sterk G, Bormans G, Himmelreich U, Casteels C, Van Laere K.

J Nucl Med. 2018 Jun;59(6):952-959. doi: 10.2967/jnumed.117.202614. Epub 2018 Mar 1.

PMID:
29496988
20.

Lower Limbic Metabotropic Glutamate Receptor 5 Availability in Alcohol Dependence.

Leurquin-Sterk G, Ceccarini J, Crunelle CL, de Laat B, Verbeek J, Deman S, Neels H, Bormans G, Peuskens H, Van Laere K.

J Nucl Med. 2018 Apr;59(4):682-690. doi: 10.2967/jnumed.117.199422. Epub 2018 Jan 18.

PMID:
29348321
21.

Moral processing deficit in behavioral variant frontotemporal dementia is associated with facial emotion recognition and brain changes in default mode and salience network areas.

Van den Stock J, Stam D, De Winter FL, Mantini D, Szmrecsanyi B, Van Laere K, Vandenberghe R, Vandenbulcke M.

Brain Behav. 2017 Nov 29;7(12):e00843. doi: 10.1002/brb3.843. eCollection 2017 Dec.

22.

Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia.

Jansen WJ, Ossenkoppele R, Tijms BM, Fagan AM, Hansson O, Klunk WE, van der Flier WM, Villemagne VL, Frisoni GB, Fleisher AS, Lleó A, Mintun MA, Wallin A, Engelborghs S, Na DL, Chételat G, Molinuevo JL, Landau SM, Mattsson N, Kornhuber J, Sabri O, Rowe CC, Parnetti L, Popp J, Fladby T, Jagust WJ, Aalten P, Lee DY, Vandenberghe R, Resende de Oliveira C, Kapaki E, Froelich L, Ivanoiu A, Gabryelewicz T, Verbeek MM, Sanchez-Juan P, Hildebrandt H, Camus V, Zboch M, Brooks DJ, Drzezga A, Rinne JO, Newberg A, de Mendonça A, Sarazin M, Rabinovici GD, Madsen K, Kramberger MG, Nordberg A, Mok V, Mroczko B, Wolk DA, Meyer PT, Tsolaki M, Scheltens P, Verhey FRJ, Visser PJ; Amyloid Biomarker Study Group, Aarsland D, Alcolea D, Alexander M, Almdahl IS, Arnold SE, Baldeiras I, Barthel H, van Berckel BNM, Blennow K, van Buchem MA, Cavedo E, Chen K, Chipi E, Cohen AD, Förster S, Fortea J, Frederiksen KS, Freund-Levi Y, Gkatzima O, Gordon MF, Grimmer T, Hampel H, Hausner L, Hellwig S, Herukka SK, Johannsen P, Klimkowicz-Mrowiec A, Köhler S, Koglin N, van Laere K, de Leon M, Lisetti V, Maier W, Marcusson J, Meulenbroek O, Møllergård HM, Morris JC, Nordlund A, Novak GP, Paraskevas GP, Perera G, Peters O, Ramakers IHGB, Rami L, Rodríguez-Rodríguez E, Roe CM, Rot U, Rüther E, Santana I, Schröder J, Seo SW, Soininen H, Spiru L, Stomrud E, Struyfs H, Teunissen CE, Vos SJB, van Waalwijk van Doorn LJC, Waldemar G, Wallin ÅK, Wiltfang J, Zetterberg H.

JAMA Psychiatry. 2018 Jan 1;75(1):84-95. doi: 10.1001/jamapsychiatry.2017.3391.

23.

Is there a glucose metabolic signature of spreading TDP-43 pathology in Amyotrophic Lateral Sclerosis?

van Weehaeghe D, Ceccarini J, Willekens SM, de Vocht J, van Damme P, van Laere K.

Q J Nucl Med Mol Imaging. 2017 Nov 22. doi: 10.23736/S1824-4785.17.03009-6. [Epub ahead of print]

PMID:
29166751
24.

Altered mGluR5 binding potential and glutamine concentration in the 6-OHDA rat model of acute Parkinson's disease and levodopa-induced dyskinesia.

Crabbé M, Van der Perren A, Weerasekera A, Himmelreich U, Baekelandt V, Van Laere K, Casteels C.

Neurobiol Aging. 2018 Jan;61:82-92. doi: 10.1016/j.neurobiolaging.2017.09.006. Epub 2017 Sep 21.

PMID:
29055799
25.

Cerebral dopaminergic and glutamatergic transmission relate to different subjective responses of acute alcohol intake: an in vivo multimodal imaging study.

Leurquin-Sterk G, Ceccarini J, Crunelle CL, Weerasekera A, de Laat B, Himmelreich U, Bormans G, Van Laere K.

Addict Biol. 2018 May;23(3):931-944. doi: 10.1111/adb.12542. Epub 2017 Sep 8.

PMID:
28884874
26.

Molecular Imaging of Human Embryonic Stem Cells Stably Expressing Human PET Reporter Genes After Zinc Finger Nuclease-Mediated Genome Editing.

Wolfs E, Holvoet B, Ordovas L, Breuls N, Helsen N, Schönberger M, Raitano S, Struys T, Vanbilloen B, Casteels C, Sampaolesi M, Van Laere K, Lambrichts I, Verfaillie CM, Deroose CM.

J Nucl Med. 2017 Oct;58(10):1659-1665. doi: 10.2967/jnumed.117.189779. Epub 2017 Jun 8.

27.

Fibrous dysplasia mimicking bone metastasis on 68GA-PSMA PET/MRI.

De Coster L, Sciot R, Everaerts W, Gheysens O, Verscuren R, Deroose CM, Pans S, Van Laere K, Goffin KE.

Eur J Nucl Med Mol Imaging. 2017 Aug;44(9):1607-1608. doi: 10.1007/s00259-017-3712-6. Epub 2017 May 9. No abstract available.

PMID:
28488027
28.

Brain PET imaging of phosphodiesterase 10A in progressive supranuclear palsy and Parkinson's disease.

Koole M, Van Laere K, Ahmad R, Ceccarini J, Bormans G, Vandenberghe W.

Mov Disord. 2017 Jun;32(6):943-945. doi: 10.1002/mds.27005. Epub 2017 Apr 10. No abstract available.

PMID:
28394032
29.

Preclinical Evaluation of 18F-JNJ64349311, a Novel PET Tracer for Tau Imaging.

Declercq L, Rombouts F, Koole M, Fierens K, Mariën J, Langlois X, Andrés JI, Schmidt M, Macdonald G, Moechars D, Vanduffel W, Tousseyn T, Vandenberghe R, Van Laere K, Verbruggen A, Bormans G.

J Nucl Med. 2017 Jun;58(6):975-981. doi: 10.2967/jnumed.116.185199. Epub 2017 Feb 23.

30.

Tandem repeats of Allium fistulosum associated with major chromosomal landmarks.

Kirov IV, Kiseleva AV, Van Laere K, Van Roy N, Khrustaleva LI.

Mol Genet Genomics. 2017 Apr;292(2):453-464. doi: 10.1007/s00438-016-1286-9. Epub 2017 Feb 1.

PMID:
28150039
31.

Towards a FISH-based karyotype of Rosa L. (Rosaceae).

Kirov IV, Van Laere K, Van Roy N, Khrustaleva LI.

Comp Cytogenet. 2016 Nov 4;10(4):543-554. doi: 10.3897/CompCytogen.v10i4.9536. eCollection 2016.

32.

The impact of reconstruction and scanner characterisation on the diagnostic capability of a normal database for [123I]FP-CIT SPECT imaging.

Dickson JC, Tossici-Bolt L, Sera T, Booij J, Ziebell M, Morbelli S, Assenbaum-Nan S, Borght TV, Pagani M, Kapucu OL, Hesse S, Van Laere K, Darcourt J, Varrone A, Tatsch K.

EJNMMI Res. 2017 Dec;7(1):10. doi: 10.1186/s13550-016-0253-0. Epub 2017 Jan 24.

33.

Abnormal dopamine transporter imaging in adult-onset Niemann-Pick disease type C.

Terbeek J, Latour P, Van Laere K, Vandenberghe W.

Parkinsonism Relat Disord. 2017 Mar;36:107-108. doi: 10.1016/j.parkreldis.2016.12.029. Epub 2017 Jan 3. No abstract available.

PMID:
28063684
34.

Striatal phosphodiesterase 10A availability is altered secondary to chronic changes in dopamine neurotransmission.

Ooms M, Celen S, De Hoogt R, Lenaerts I, Liebregts J, Vanhoof G, Langlois X, Postnov A, Koole M, Verbruggen A, Van Laere K, Bormans G.

EJNMMI Radiopharm Chem. 2017;1(1):3. doi: 10.1186/s41181-016-0005-5. Epub 2016 Mar 21.

35.

Cholinergic depletion and basal forebrain volume in primary progressive aphasia.

Schaeverbeke J, Evenepoel C, Bruffaerts R, Van Laere K, Bormans G, Dries E, Tousseyn T, Nelissen N, Peeters R, Vandenbulcke M, Dupont P, Vandenberghe R.

Neuroimage Clin. 2016 Dec 2;13:271-279. doi: 10.1016/j.nicl.2016.11.027. eCollection 2017.

36.

Positron emission tomography in amyotrophic lateral sclerosis: Towards targeting of molecular pathological hallmarks.

Willekens SM, Van Weehaeghe D, Van Damme P, Van Laere K.

Eur J Nucl Med Mol Imaging. 2017 Mar;44(3):533-547. doi: 10.1007/s00259-016-3587-y. Epub 2016 Dec 8. Review.

PMID:
27933416
37.

Positive Association Between Limbic Metabotropic Glutamate Receptor 5 Availability and Novelty-Seeking Temperament in Humans: An 18F-FPEB PET Study.

Leurquin-Sterk G, Van den Stock J, Crunelle CL, de Laat B, Weerasekera A, Himmelreich U, Bormans G, Van Laere K.

J Nucl Med. 2016 Nov;57(11):1746-1752. Epub 2016 Jun 9.

38.

Synthesis, Biodistribution and In vitro Evaluation of Brain Permeable High Affinity Type 2 Cannabinoid Receptor Agonists [11C]MA2 and [18F]MA3.

Ahamed M, van Veghel D, Ullmer C, Van Laere K, Verbruggen A, Bormans GM.

Front Neurosci. 2016 Sep 22;10:431. eCollection 2016.

39.

[18F]JNJ42259152 binding to phosphodiesterase 10A, a key regulator of medium spiny neuron excitability, is altered in the presence of cyclic AMP.

Ooms M, Attili B, Celen S, Koole M, Verbruggen A, Van Laere K, Bormans G.

J Neurochem. 2016 Dec;139(5):897-906. doi: 10.1111/jnc.13855. Epub 2016 Nov 4.

40.

Differential brain responses to gradual intragastric nutrient infusion and gastric balloon distension: A role for gut peptides?

Ly HG, Dupont P, Van Laere K, Depoortere I, Tack J, Van Oudenhove L.

Neuroimage. 2017 Jan 1;144(Pt A):101-112. doi: 10.1016/j.neuroimage.2016.09.032. Epub 2016 Sep 14.

PMID:
27639359
41.

No Association of Lower Hippocampal Volume With Alzheimer's Disease Pathology in Late-Life Depression.

De Winter FL, Emsell L, Bouckaert F, Claes L, Jain S, Farrar G, Billiet T, Evers S, Van den Stock J, Sienaert P, Obbels J, Sunaert S, Adamczuk K, Vandenberghe R, Van Laere K, Vandenbulcke M.

Am J Psychiatry. 2017 Mar 1;174(3):237-245. doi: 10.1176/appi.ajp.2016.16030319. Epub 2016 Aug 19.

PMID:
27539488
42.

Decreased in vivo availability of the cannabinoid type 2 receptor in Alzheimer's disease.

Ahmad R, Postnov A, Bormans G, Versijpt J, Vandenbulcke M, Van Laere K.

Eur J Nucl Med Mol Imaging. 2016 Nov;43(12):2219-2227. Epub 2016 Aug 3.

PMID:
27488857
43.

SNMMI Procedure Standard/EANM Practice Guideline for Amyloid PET Imaging of the Brain 1.0.

Minoshima S, Drzezga AE, Barthel H, Bohnen N, Djekidel M, Lewis DH, Mathis CA, McConathy J, Nordberg A, Sabri O, Seibyl JP, Stokes MK, Van Laere K.

J Nucl Med. 2016 Aug;57(8):1316-22. doi: 10.2967/jnumed.116.174615. No abstract available.

44.

What We Observe In Vivo Is Not Always What We See In Vitro: Development and Validation of 11C-JNJ-42491293, A Novel Radioligand for mGluR2.

Leurquin-Sterk G, Celen S, Van Laere K, Koole M, Bormans G, Langlois X, Van Hecken A, Te Riele P, Alcázar J, Verbruggen A, de Hoon J, Andrés JI, Schmidt ME.

J Nucl Med. 2017 Jan;58(1):110-116. doi: 10.2967/jnumed.116.176628. Epub 2016 Jul 28.

45.

Single-photon emission tomography.

Goffin K, van Laere K.

Handb Clin Neurol. 2016;135:241-250. doi: 10.1016/B978-0-444-53485-9.00013-1. Review.

PMID:
27432669
46.

Association between cerebral cannabinoid 1 receptor availability and body mass index in patients with food intake disorders and healthy subjects: a [(18)F]MK-9470 PET study.

Ceccarini J, Weltens N, Ly HG, Tack J, Van Oudenhove L, Van Laere K.

Transl Psychiatry. 2016 Jul 12;6(7):e853. doi: 10.1038/tp.2016.118.

47.

Face shape and face identity processing in behavioral variant fronto-temporal dementia: A specific deficit for familiarity and name recognition of famous faces.

De Winter FL, Timmers D, de Gelder B, Van Orshoven M, Vieren M, Bouckaert M, Cypers G, Caekebeke J, Van de Vliet L, Goffin K, Van Laere K, Sunaert S, Vandenberghe R, Vandenbulcke M, Van den Stock J.

Neuroimage Clin. 2016 Mar 10;11:368-377. doi: 10.1016/j.nicl.2016.03.001. eCollection 2016.

48.

Functional Changes in the Language Network in Response to Increased Amyloid β Deposition in Cognitively Intact Older Adults.

Adamczuk K, De Weer AS, Nelissen N, Dupont P, Sunaert S, Bettens K, Sleegers K, Van Broeckhoven C, Van Laere K, Vandenberghe R.

Cereb Cortex. 2017 Jul 1;27(7):3879. doi: 10.1093/cercor/bhw117. No abstract available.

PMID:
27226443
49.

Preclinical Evaluation of a P2X7 Receptor-Selective Radiotracer: PET Studies in a Rat Model with Local Overexpression of the Human P2X7 Receptor and in Nonhuman Primates.

Ory D, Celen S, Gijsbers R, Van Den Haute C, Postnov A, Koole M, Vandeputte C, Andrés JI, Alcazar J, De Angelis M, Langlois X, Bhattacharya A, Schmidt M, Letavic MA, Vanduffel W, Van Laere K, Verbruggen A, Debyser Z, Bormans G.

J Nucl Med. 2016 Sep;57(9):1436-41. doi: 10.2967/jnumed.115.169995. Epub 2016 May 19.

50.

Functional integration changes in regional brain glucose metabolism from childhood to adulthood.

Trotta N, Archambaud F, Goldman S, Baete K, Van Laere K, Wens V, Van Bogaert P, Chiron C, De Tiège X.

Hum Brain Mapp. 2016 Aug;37(8):3017-30. doi: 10.1002/hbm.23223. Epub 2016 May 2.

PMID:
27133021

Supplemental Content

Loading ...
Support Center